174,99 €
The Essential Guide to Recognizing and Treating Acute Endocrine and Metabolic Illness Endocrinology covers some of the most common conditions and serious public health challenges facing medicine today, and endocrine and metabolic emergencies constitute a large proportion of the clinical workload. Endocrine and Metabolic Medical Emergencies: A Clinician's Guide provides a singular reference to help endocrinologists, acute and general medicine clinicians, hospitalists and critical care physicians, and general practitioners recognize the symptoms of endocrine emergencies and provide the highest standards of care. Already the definitive and most comprehensive guide to endocrine emergency care, this new second edition: provides acute care guidance for a range of both common and unusual endocrine emergencies; details the effects of acute medical and critical illness on metabolic and endocrine systems, and their impacts on endocrine investigations; discusses special patient populations, including the impacts of aging, pregnancy, transplantation, late-effects, perioperative, inherited metabolic disorders and HIV/AIDS on presentation and management; and features detailed coverage of disorders by system, as well as, metabolic bone diseases, neuroendocrine tumors, and more. Packed with case studies, images, and chapters written by distinguished authors, this guide is designed for both quick reference and study. Coverage includes the presentation, diagnosis, management, and treatment of endocrine and metabolic disorders in an acute care setting, as well as the most up-to-date guidance on issues including clinical lipidology, glucose, sodium, calcium and phosphate, and more. Blending the latest science with clinical and practical advice, this invaluable resource helps clinicians stay up to date with the field's relevant body of knowledge while providing the practical, clinical insight they need in order to provide their patients with the utmost level of care.
Sie lesen das E-Book in den Legimi-Apps auf:
Seitenzahl: 1852
Veröffentlichungsjahr: 2018
I dedicate this book to all people living with endocrine and metabolic problems and the healthcare professionals who look after them. I also dedicate this book to my family, especially wife Marcia and parents Enid and Sid, without whose continued support and encouragement the book would never have been started never mind finished!
Edited by
Glenn Matfin, BSc (Hons), MSc (Oxon), MB ChB, DGM, FACE, FACP, FRCP
Consultant in Acute and General Medicine, Diabetes and Endocrinology Honorary Professor of Medicine National Health Service, UK Professor of Medicine MBRU College of Medicine Dubai Healthcare City Dubai, UAE
Second Edition
This Work is a co-publication between the Endocrine Society and John Wiley & Sons, Ltd.
This first published 2018© 2018 John Wiley & Sons Ltd
This Work is a co-publication between the Endocrine Society and John Wiley & Sons, Ltd.
Edition HistoryEndocrine Society/Endocrine Press (1e, 2014)
All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by law. Advice on how to obtain permission to reuse material from this title is available at http://www.wiley.com/go/permissions.
The right of Glenn Matfin to be identified as the author of this work has been asserted in accordance with law.
Registered Office(s)John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030, USA John Wiley & Sons Ltd, The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK
Editorial Office9600 Garsington Road, Oxford, OX4 2DQ, UK
For details of our global editorial offices, customer services, and more information about Wiley products visit us at www.wiley.com.
Wiley also publishes its books in a variety of electronic formats and by print-on-demand. Some content that appears in standard print versions of this book may not be available in other formats.
Limit of Liability/Disclaimer of Warranty The contents of this work are intended to further general scientific research, understanding, and discussion only and are not intended and should not be relied upon as recommending or promoting scientific method, diagnosis, or treatment by physicians for any particular patient. In view of ongoing research, equipment modifications, changes in governmental regulations, and the constant flow of information relating to the use of medicines, equipment, and devices, the reader is urged to review and evaluate the information provided in the package insert or instructions for each medicine, equipment, or device for, among other things, any changes in the instructions or indication of usage and for added warnings and precautions. While the publisher and authors have used their best efforts in preparing this work, they make no representations or warranties with respect to the accuracy or completeness of the contents of this work and specifically disclaim all warranties, including without limitation any implied warranties of merchantability or fitness for a particular purpose. No warranty may be created or extended by sales representatives, written sales materials or promotional statements for this work. The fact that an organization, website, or product is referred to in this work as a citation and/or potential source of further information does not mean that the publisher and authors endorse the information or services the organization, website, or product may provide or recommendations it may make. This work is sold with the understanding that the publisher is not engaged in rendering professional services. The advice and strategies contained herein may not be suitable for your situation. You should consult with a specialist where appropriate. Further, readers should be aware that websites listed in this work may have changed or disappeared between when this work was written and when it is read. Neither the publisher nor authors shall be liable for any loss of profit or any other commercial damages, including but not limited to special, incidental, consequential, or other damages.
Library of Congress Cataloging-in-Publication Data
Names: Matfin, Glenn, editor.Title: Endocrine and metabolic medical emergencies : a clinician's guide / [edited] by Glenn Matfin.Description: Second edition. | Hoboken, NJ : Wiley, 2018. | Includes bibliographical references and index. | Identifiers: LCCN 2017049999 (print) | LCCN 2017050741 (ebook) | ISBN 9781119374763 (pdf) | ISBN 9781119374756 (epub) | ISBN 9781119374732 (cloth)Subjects: | MESH: Endocrine System Diseases | Metabolic Diseases | Emergency TreatmentClassification: LCC RC649 (ebook) | LCC RC649 (print) | NLM WK 140 | DDC 616.4–dc23LC record available at https://lccn.loc.gov/2017049999
Cover images: ©donskarpo / Getty Images-Thyroid level conceptual meter©shansekala / Getty Images-Stethoscope on cardiogram concept for heart care©juststock / Getty Images-Hypoglycemia Printed Diagnosis Medical ConceptCover design by Wiley
1 2018
Notes on Contributors
Foreword
Preface
List of Abbreviations
Part I General Aspects of Acute Medical Emergencies
Introduction Acute Medical Care: A Crisis with Solutions
Introduction
What Is the Impact of the Acute Medical Crisis on Diabetes and Endocrinology Speciality Delivery?
Solutions/Opportunities
Acknowledgments
References
1 Early Management of Acute Medical Emergencies
Introduction
Recognition of Medical Emergencies
The ABCDE Approach
Definitive Diagnosis and Treatment
Conclusions
References
Part II General Endocrine and Metabolic Aspects of Acute and Critical Illness
Introduction Endocrine Testing and Responses in Acute and Critical Illness
Acknowledgments
References
2 Endocrine Testing in Acute and Critical Illness
Introduction
Factors Influencing Laboratory Hormone Results or Their Interpretation in Acute Illness
Examples of Endocrine System Testing in Acute and Critical Illness
Hypothalamic-Pituitary-Thyroid (HPT) Axis
The Hypothalamic-Pituitary-Adrenal (HPA) Axis
Catecholamines
Hypothalamic-Pituitary Gonadal (HPG) Axis
Growth Hormone and Insulin-Like Growth Factor-1
Vitamin D
Conclusions
References
3 Endocrine Responses to Critical Illness
Introduction
Hypothalamic-Pituitary-Thyroid Axis
Hypothalamic-Pituitary-Adrenal Axis
The Hyperglycemic Response to Critical Illness: To Treat or Not to Treat?
Conclusions
Acknowledgments
References
Part III Special Populations
4 Endocrine and Metabolic Emergencies in Pregnancy
Introduction
Diabetes Mellitus
Pituitary Disease
Adrenal Disease
Thyroid Disease in Pregnancy
Parathyroid Disease in Pregnancy
Conclusions
References
5 Endocrine and Metabolic Emergencies in Inherited Metabolic Diseases
Introduction
Rhabdomyolysis
Encephalopathy
Acute Adrenal Crisis
Stroke
Cardiac Disease
Psychiatric Presentations
Pregnancy
Conclusions
References
6 Endocrine and Metabolic Emergencies in Transitional Care
Introduction
Type 1 Diabetes Mellitus
Hyperglycemic Hyperosmolar State (HHS)
Autoimmune Polyglandular Syndromes (APS)
Adrenal Insufficiency
Endocrine Hypertension
Traumatic Brain Injury (TBI)
Growth Hormone Deficiency (GHD)
Diabetes Insipidus (DI)
Hypothyroidism
Conclusions
References
7 Emergency Perioperative Diabetes and Endocrine Management
Introduction
Emergency Perioperative Diabetes and/or Hyperglycemia Management
Approaches to Management of Perioperative Diabetes and/or Hyperglycemia
Emergency Perioperative Endocrine and Metabolic Management
Pituitary
Thyroid
Adrenal Crisis
Sodium Level
Calcium
Neuroendocrine Tumors (NETs)
Conclusions
References
8 Endocrine and Metabolic Emergencies in HIV/AIDS
Introduction
Hypoadrenalism
Lactic Acidosis and Mitochondrial Toxicity
Hyperglycemia
Hypertriglyceridemia
Thyrotoxicosis
Hypercalcemia
Conclusions
References
9 Endocrine and Metabolic Emergencies in Late-Effects Patients
Introduction
Organization of Care for Cancer Survivors
Adrenal Insufficiency
Radiation Affecting the Hypothalamic Pituitary Axis
Adrenal Suppression Following Glucocorticoids
Immune Checkpoint Inhibitors and Endocrine Dysfunction
Thyroid Dysfunction
Diabetes Insipidus
Metabolic Disorders
Other Non-Endocrine Consequences
Conclusions
References
10 Endocrine and Metabolic Emergencies in Transplantation
Introduction
Hyperglycemia
Hypoglycemia
Dyslipidemia
Pituitary Disease
Adrenal Disease
Thyroid Disease
Calcium and Phosphate Disorders
Hypercalcemia
Hypocalcemia
Hypophosphatemia
Conclusions
References
11 Endocrine and Metabolic Changes with Aging: Endocrin-Aging: Recognizing and Managing Care in Older Frail Persons
Introduction
Pituitary Dysfunction in the Elderly
Hypothyroidism
Hyperthyroidism
Primary Adrenal Insufficiency (Addison's Disease)
Type 2 Diabetes Mellitus
Hyperglycemic Crisis
Hypoglycemia
Hypercalcemia
Sarcopenia and Hormones
Conclusions
References
Part IV Pituitary Disorders
Introduction Emergency Management of Pituitary Disorders
Conclusions
References
12 Hypopituitarism
Introduction
Etiology
Pathophysiology
Clinical Features and Findings
Conclusions
References
13 Pituitary Apoplexy
Introduction
Predisposing and Precipitating Factors
Pathophysiology
Clinical Presentation
Endocrine Dysfunction
Diagnostic Evaluation
Management of Pituitary Apoplexy
Conclusions
References
14 Macroprolactinomas
Introduction
Visual Field Defect at Presentation
Cerebrospinal Fluid (CSF) Rhinorrhea
Pituitary Apoplexy
Tumor Enlargement during Pregnancy
Conclusions
References
Part V Thyroid Disorders
Introduction Emergency Management of Thyroid Disorders
Introduction
Thyroid Emergencies
Conclusions
References
15 Myxedema Coma
Introduction
Pathophysiology
Clinical Manifestations
Prognosis
Conclusions
References
16 Life-Threatening Thyrotoxicosis: Thyroid Storm and Adverse Effects of Antithyroid Drugs
Introduction
Clinical Presentation
Treatment
After the Storm: Definitive Treatment
Prevention of Thyroid Storm
Adverse Effects of Antithyroid Drugs
Conclusions
Acknowledgments
References
17 Amiodarone-Induced Thyrotoxicosis
Introduction
Pathophysiology
Amiodarone-Induced Thyroid Disease
Conclusions
References
18 Thyrotoxic Periodic Paralysis
Introduction
Pathophysiology
Clinical Features
Conclusions
Acknowledgments
References
19 Sight-Threatening Graves’ Orbitopathy
Introduction
Pathophysiology
Dysthyroid Optic Neuropathy (DON)
Corneal Breakdown
Subluxation of the Globe
Conclusions
References
Part VI Adrenal Disorders
Introduction Emergency Management of Adrenal Disorders
Introduction
Pheochromocytoma and Paraganglioma
Primary Aldosteronism
Incidentally Discovered Adrenal Tumors
Conclusions
References
20 Acute Adrenal Insufficiency
Introduction
Pathophysiology
Etiology of Adrenal Insufficiency
Clinical Assessment
Diagnostic Testing of Adrenal Insufficiency
Treatment
Treatment of Precipitating Illness
Special Populations
Prevention of Adrenal Crisis
Conclusions
References
21 Acute Medical Aspects Related to Florid Cushing's Syndrome
Introduction
Etiology
Florid Cushing's Syndrome Investigation
Clinical Signs and Features
Management
Diagnostic Considerations
Conclusions
References
22 Endocrine Hypertensive Emergencies
Introduction
Hypertensive Emergencies
Pathogenesis
Hypertensive Emergencies Associated with Pheochromocytoma
Other Endocrine Causes of Hypertensive Emergencies
Diagnostic Considerations
Clues to Endocrine Causes of Hypertensive Emergencies
Treatment of Hypertensive Emergencies
Treatment of Pheochromocytoma-Related Hypertensive Emergencies
Treatment of Other Endocrine Hypertensive Emergencies
Conclusions
References
Part VII Calcium, Phosphate, and Metabolic Bone Diseases
Introduction Emergency Management of Calcium, Phosphate, and Metabolic Bone Diseases
23 Hypocalcemia
Introduction
Pathophysiology
Etiology
Diagnostic Considerations
Clinical Assessment
Acute Intervention
Permanent Hypoparathyroidism
Emerging Therapies
Conclusions
Acknowledgments
References
24 Hypercalcemia
Introduction
Pathophysiology
Etiology
Diagnostic Considerations
Clinical Signs and Features
Management of Severe Hypercalcemia
Treatment of Precipitating Illness
Emerging Treatments
Hypercalcemia in Pregnancy
Conclusions
References
25 Acute Medical Aspects Related to Phosphate Disorders
Introduction
Pathophysiology of Phosphate Homeostasis
Hypophosphatemia as a Metabolic Emergency
Hyperphosphatemia as a Metabolic Emergency
Conclusions
Acknowledgments
References
26 Acute Medical Aspects Related to Osteoporosis and Its Therapy
Introduction
Safety Concerns with Osteoporosis Therapy
Work-Up and Management of the Acute Fragility Fracture
Conclusions
References
27 Acute Medical Aspects Related to Paget's Disease of Bone
Introduction
Severe Bone Pain in Persons with Paget's Disease
Neurological Complications of Paget's Disease
Hypercalcemia
High Output Cardiac Failure
Conclusions
References
28 Acute Medical Aspects Related to Kidney Stones
Introduction
Epidemiology
Pathophysiology
Pathology
Differential Diagnosis
Risk Factors
Emergency Care Evaluation
Management
Prevention of Recurrence
Conclusions
References
Part VIII Neuroendocrine Tumors
Introduction Emergency Management of Neuroendocrine Tumors
Introduction
Small Intestinal NETs
Pancreatic NETs
Syndromes Related to Ectopic Hormonal Secretion
Conclusions
References
29 Acute Endocrine and Metabolic Emergencies Related to Neuroendocrine Tumors
Introduction
Specific Tumors and Situations
Syndromes Related to Ectopic Hormonal Secretion
Conclusions
References
Part IX Glucose Disorders
Introduction Emergency Management of Glucose Disorders
Introduction
References
30 Management of Diabetes and/or Hyperglycemia in Non-Critical Care Hospital Settings
Introduction
Inpatient Hyperglycemia and Hypoglycemia: A Brief Definition
Prevalence of Hyperglycemia and Hypoglycemia in Non-Critical Care Settings
Hyperglycemia and Outcomes in Non-Critical Care Settings
Hypoglycemia and Outcomes in Non-Critical Care Hospital Settings
Glycemic Variability
Management of Inpatient Hyperglycemia in Non-Critically Ill Hospitalized Patients
Personalized Hyperglycemia Management in Non-Critical Care Settings: A New Paradigm
Hospital Use of Incretin Therapy in Non-Critical Care Settings
Recommendations After Hospital Discharge
Conclusions
References
31 Hypoglycemia
Introduction
Definition of Hypoglycemia
Epidemiology
Glucose Measurements
Physiology of Glucose Metabolism
Management of Hypoglycemia
Etiology
Conclusions
Acknowledgments
References
32 Severe Hyperglycemia, Diabetic Ketoacidosis, and Hyperglycemic Hyperosmolar State
Introduction
Pathophysiology
Etiology
Diagnostic Considerations
Clinical Signs and Features
Management of Severe Hyperglycemia, DKA, and HHS
Treatment of Precipitating Illness
DKA in Pregnancy
Conclusions
References
33 Short-Term Intensive Insulin Therapy in Patients with Newly Presenting Type 2 Diabetes
Introduction
Clinical Evidence of STII Therapy in Newly Presenting T2DM
Clinical Practice of STII Therapy in Newly Presenting T2DM
Conclusions
References
34 Management of Concentrated Insulins in Acute Care Settings
Introduction
Background to Concentrated Insulins
Admission
During Hospitalization
Discharge
Conclusions
References
35 Management of Insulin Pumps in Hospitalized Patients
Introduction
Contexts of Inpatient CSII Therapy
General Considerations
Contraindications to Inpatient CSII Self-Management
Patient Agreement
Admission/Post-admission Procedures
Practical Experience with Inpatient CSII Self-Management
Continuous Glucose Monitoring Systems
Specific Scenarios
Use of CSII in the Perioperative Period
Limitations of Guidelines
Conclusions
References
36 Management of Diabetes and/or Hyperglycemia during Enteral and Parenteral Nutrition
Introduction
Glycemic Goals in Patients Receiving Enteral and Parenteral Nutrition
Managing Hyperglycemia in Patients During Specialized Nutrition Support
Lipid Management Issues Unique to PN
Hospital Discharge Diabetes Management Options for Patients Receiving Specialized Nutrition Support
Hypoglycemia in Patients Receiving Specialized Nutrition Support
Conclusions
Acknowledgments
References
37 Management of Diabetes and/or Hyperglycemia in Hospitalized Patients with Renal Insufficiency
Introduction
Diabetes, Hypoglycemia, and Chronic Kidney Disease
Insulin Therapy in Patients with Diabetes and/or Hyperglycemia in CKD/ESRD
Non-Insulin Therapies in Patients with Diabetes and/or Hyperglycemia in CKD/ESRD
Diagnosis and Management of Diabetic Ketoacidosis in Advanced CKD/ESRD
Practical Management of Diabetes and/or Hyperglycemia in CKD/ESRD
Conclusions
Acknowledgments
References
38 Management of Glucocorticoid-Induced Diabetes and/or Hyperglycemia
Introduction
Definition
Prevalence
Risk Factors for the Development of GID
Common Glucocorticoid Regimens
Pathophysiology and Pattern of GIH
Diagnosis
Associated Adverse Outcomes
Treatment Options
General Management Approach
Conclusions
References
39 Management of Diabetes and/or Hyperglycemia in Acute Coronary Syndrome, Acute Stroke, and Acute Heart Failure
Introduction
Acute Coronary Syndromes
Strokes and TIAs
Heart Failure
Conclusions
References
40 Acute Diabetic Foot
Introduction
Prevention of Diabetes Foot Complications
Classification and Diagnosis
Management of Diabetic Foot Infections
Osteomyelitis
Necrotizing Fasciitis
Charcot Neuroarthropathy
Peripheral Arterial Disease (PAD)
Discharge Planning
Conclusions
Acknowledgments
References
Part X Sodium Disorders
Introduction Emergency Management of Sodium Disorders
References
41 Emergency Management of Acute and Chronic Hyponatremia
Introduction
Classification of Hyponatremia by Plasma Tonicity, Extracellular Fluid Volume Status, and Severity
Hyponatremia Symptoms, Morbidity, and Mortality
Treatment of Symptomatic Hyponatremia: General Principles
Currently Available Therapies for Treatment of Symptomatic Hyponatremia
Hyponatremia Treatment Guidelines Based on Symptom Severity
Monitoring the Serum [Na
+
] in Hyponatremic Patients
Common Clinical Questions about the Therapy of Symptomatic Hyponatremia
References
42 Emergency Management of Acute and Chronic Hypernatremia
Introduction
The Physiological Control of Water Balance
Causes of Hypernatremia
Consequences of Hypernatremia
Management of Acute Hypernatremia
Management of Chronic Hypernatremia
Conclusions
References
Part XI Obesity and Clinical Lipidology
Introduction Emergency Management Related to Obesity and Clinical Lipidology
Obesity
Clinical Lipidology
References
43 Acute Emergencies Related to Bariatric Surgery
Introduction
Bariatric Procedures
Bariatric Surgery-Related Issues
Conclusions
References
44 Chylomicronemia Syndrome: Very Severe Hypertriglyceridemia and Acute Pancreatitis
Introduction
History
Epidemiology
Pathophysiology
Etiology
Clinical Features
Investigations
Treatment
Conclusions
Acknowledgments
References
45 Statin-Related Myopathy and Rhabdomyolysis
Introduction
Definition of Terms
Historical Background
Risk Factors and Prevention of Myopathy/Rhabdomyolysis
Statin-Associated Muscle Symptoms (SAMS)
Muscle Symptoms with CK ≥ 5 to 10 × ULN
Myopathy
Rhabdomyolysis
Conclusions
References
Index
Wiley End User License Agreement
Chapter 1
Table 1.1
Table 1.2
Table 1.3
Chapter 2
Table 2.1
Chapter 3
Table 3.1
Chapter 4
Table 4.1
Chapter 5
Table 5.1
Table 5.2
Table 5.3
Chapter 6
Table 6.1
Table 6.2
Chapter 8
Table 8.1
Chapter 9
Table 9.1
Chapter 10
Table 10.1
Table 10.2
Chapter 11
Table 11.1
Table 11.2
Table 11.3
Table 11.4
Chapter 12
Table 12.1
Table 12.2
Table 12.3
Chapter 13
Table 13.1
Chapter 14
Table 14.1
Chapter 15
Table 15.1
Table 15.2
Table 15.3
Table 15.4
Chapter 16
Table 16.1
Table 16.2
Table 16.3
Table 16.4
Table 16.5
Table 16.6
Chapter 17
Table 17.1
Table 17.2
Chapter 18
Table 18.1
Table 18.2
Chapter 3
Table 19.1
Chapter 20
Table 20.1
Table 20.2
Table 20.3
Table 20.4
Chapter 22
Table 22.1
Table 22.2
Table 22.3
Table 22.4
Chapter 23
Table 23.1
Table 23.2
Table 23.3
Table 23.4
Chapter 24
Table 24.1
Table 24.2
Table 24.3
Table 24.4
Chapter 25
Table 25.1
Table 25.2
Table 25.3
Chapter 26
Table 26.1
Table 26.2
Chapter 27
Table 27.1
Table 27.2
Chapter 28
Table 28.1
Chapter 29
Table 29.1
Chapter 30
Table 30.1
Chapter 31
Table 31.1
Table 31.2
Table 31.3
Table 31.4
Chapter 32
Table 32.1
Table 32.2
Table 32.3
Chapter 33
Table 33.1
Chapter 34
Table 34.1
Table 34.2
Table 34.3
Table 34.4
Table 34.5
Table 34.6
Table 34.7
Chapter 35
Table 35.1
Table 35.2
Chapter 36
Table 36.1
Table 36.2
Table 36.3
Table 36.4
Chapter 37
Table 37.1
Table 37.2
Table 37.3
Table 37.4
Chapter 38
Table 38.1
Table 38.2
Chapter 39
Table 39.1
Table 39.2
Table 39.3
Table 39.4
Table 39.5
Chapter 40
Table 40.1
Table 40.2
Table 40.3
Table 40.4
Table 40.5
Table 40.6
Table 40.7
Chapter 41
Table 41.1
Table 41.2
Table 41.3
Table 41.4
Table 41.5
Chapter 42
Table 42.1
Table 42.2
Table 42.3
Chapter 43
Table 43.1
Table 43.2
Table 43.3
Chapter 44
Table 44.1
Table 44.2
Table 44.3
Table 44.4
Chapter 45
Table 45.1
Table 45.2
Table 45.3
Table 45.4
Cover
Table of Contents
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
10
11
12
13
14
15
16
17
18
19
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
472
473
474
475
476
477
478
479
480
481
482
483
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
e1
iii
xvi
xvii
xviii
xix
xx
xxi
1
2
3
4
5
6
7
8
9
21
22
23
24
25
26
27
83
195
196
197
198
199
200
201
243
245
246
247
248
251
313
315
316
317
318
319
320
375
377
378
379
465
467
468
469
470
471
485
487
488
489
490
673
674
675
676
677
678
717
719
720
721
722
C1
ii
iv
x
xi
xii
xiii
xiv
xv
